Scribd
Upload
27 views1 page

Two Years Follow-Up Results of Real World Experience of Bioresorbable Scaffolds (BRS)

From cute drawstring totes to wanderer headphones, Typo has stylish home décor, lighting & stationery to suit you.

Uploaded by

ashutoshkumar5549
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
27 views1 page

Two Years Follow-Up Results of Real World Experience of Bioresorbable Scaffolds (BRS)

From cute drawstring totes to wanderer headphones, Typo has stylish home décor, lighting & stationery to suit you.

Uploaded by

ashutoshkumar5549
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
You are on page 1/ 1

Two Years Follow-up Results of Real World Experience of Bioresorbable Scaffolds (BRS)

T. Ghose*, R. Kachru*, A. Hussain*, B. Kukreti**, K. Arora**, U. Kaul*,


Fortis Flt. Lt. Rajan Dhall Hospital, New Delhi, India*
Paras Hospital, Gurgaon, India**
Abstract Results
Bio Resorbable Scaffold (BRS) is a new device in Total of 357 BRS were deployed in 290 patients. The mean age of the patients were 47 +/- 20.5yrs. 233
the field of coronary intervention. It has been patients (80.34%) were males. 255(87.93%) procedures were through transradial route. Diabetes
introduced for the last few years in various parts mellitus (n=81, 27.93 %), hypertension (n=112, 38.62%), dyslipidemia (n=102 , 35.72%), smoking (n=70 ,
of the world. Follow up data of BRS usage in 24.13%), family history of CAD (n=58,20%) and obesity (n=73,25.17%) were the risk factors. 40 BRS
Asian patients is sparse. We conducted a clinical were deployed in non ACS lesions, 227 in ACS/NSTEMI lesions and 90 in ST elevation MI (STEMI) lesions.
follow up study of all patients who received BRS 3 patients had day care angioplasty. Total 90 scaffolds were deployed in various lesions of STEMI.
for various indications in two centres.` Among them 16 scaffolds were deployed without pre-dilatations of STEMI lesion. Aspirin plus either
clopidogrel or prasugrel or ticagrelor was the DAPT regimen followed. 69 (23.79%) patients received
bivaluridin , 203 (70 %) patients received GPIIb3a inhibitor.Post procedure TIMI flow was as follows :
Material & Methods TIMI III-287 and TIMI II in 3 patients. Peri procedural events were as follows: (1) use of buddy were 8 ,
(2) strut fracture 3 , (3) under expansion 1 , (4) Sub acute thrombosis 5 , coronary rupture -1 . All
Hospital records of all patients who received BRS patients were discharged between 2 to 5 days except day care angioplasty patients. 284(97.93%)
were analysed. Cardiac catheterization patients could be contacted. The mean duration of follow up was 25 +/-11.5 months. There were 2
laboratory data sheet, discharge records were deaths. One patient died from cardiogenic shock during the index hospitalization, one patient had
cross checked. Demography, procedural details cardiac arrest at 2 months follow up. 16 patients were re-hospitalized (CHF-4; non CV cause-6; SAT-6,
and hospital stay were analysed. All patients 2.06 %). Repeat revascularization procedure = 6 (2.06%) ; TLR = 5 , TVR =1 .
were contacted telephonically by study team
under the guidance of the treating physician. Conclusion
Recurrence of angina, DAPT continuation,
`
From this analysis we conclude that use of BRS is Indian patients is safe at mean clinical follow up of
bleeding, hospitalization and death were twenty five months. We recommended continuations of DAPT in these patients. The duration of
specifically enquired. Study period was between DAPT will be clear from the further follow up of these patients.
Feb 2013 and Aug 2016.

You might also like